Abstract
The distribution of radio-labeled ACNU, MTX and 5-FU in brain and tumor tissue was studied in female Wistar rats by macroautoradiography after intrathecal administration. In normal rats, ACNU and 5-FU, administered intracisternally, distributed rapidly in the subarachnoid space, ventricular system and cerebrospinal fluid (CSF). 5-FU and MTX penetrated the brain deeply; the diffusional transport of ACNU was limited to a depth of 1 or 2 mm from the CSF surface of the brain. MTX and 5-FU clearance into the blood circulation was rather slow while ACNU cleared relatively quickly. The half time of ACNU, 5-FU and MTX radioactivity at the ventricular surface was 10, 21, and 110 min, respectively, at their maximal concentration after intracisternal administration. In rats with leptomeningeal tumor induced by intracisternal inoculation of Walker 256 cells, the distribution patterns of ACNU, 5-FU, and MTX were essentially the same as in normal rats despite 10–20 cell layers of tumor growing in the subarachnoid space. 5-FU and MTX were able to penetrate tumor masses in the subarachnoid space; MTX penetration was slower than that of 5-FU and ACNU failed to penetrate to more than a depth of 1 or 2 mm from the tumor surface.
Similar content being viewed by others
References
Shapiro WR, Posner JB, Ushio Y, Chernik NL, Young DF: Treatment of meningeal neoplasms. Cancer Treat Rep 61: 733–743, 1997
Bleyer WA: Current status of intrathecal chemotherapy for human meningeal neoplasms. Natl Cancer Inst Monogr 46: 171–178, 1997
Ushio Y, Hayakawa T, Hasegawa H, Yamada K, Arita N: Chemotherapy of malignant gliomas. Neurosurg Rev 7: 3–12, 1984
Ushio Y, Shimizu K, Aragaki Y, Arita N, Hayakawa T, Mogami H: Alteration of blood CSF barrier by tumor invasion into the meninges. J Neurosurg 55: 445–449, 1981
Levin VA, Landahl HD, Freeman-Done MA: The application of brain capillary permeability coefficient measurements to pathological condition and the selection of agents which cross the blood–brain barrier. J Pharmacokin Biopharm 4: 499–519, 1976
Fenstermacher JD, Patlak CS, Blasberg RG: Transport of material between brain extracellular fluid, brain cells and blood. Fed Proc 33: 2070–2074, 1974
Huang TY, Arita N, Ushio Y, Hayakawa T, Yamada K: Pharmacokinetics of intrathecal 1-(4-amino-2-methyl-5-pyrimidinyl) methyl-3-(2-chloroethyl)-3-nitrosourea hydrochloride in rats. J Neuro-Oncol 19: 245–250, 1994
Nagatani M, Arita N, Ushio Y, Hayakawa T, Huang TY, Yoshimine T, Mori S, Mogami H: Intrathecal ACNU against malignant leptomeningeal tumors: toxicity and therapeutic effect on experimental animals. Brain and Nerve (Tokyo) 38: 1071–1075, 1986 (in Japanese with English abstract)
Goldman ID, Matherly LH: The cellular pharmacology of methotrexate. Pharmac Ther 28: 77–101, 1985
Balis FM, Poplack DG: Central nervous system pharmacology of antileukemic drugs. Amer J Pediatric Hematol-Oncol 11(1): 74–86, 1989
Ushio Y, Chernik NL, Posner JB, Shapiro WR: Meningeal carcinomatosis: development of an experimental model. J Neuropathol Exp Neurol 36: 228–244, 1977
Blasberg RG, Patlak C, Fenstermacher JD: Intrathecal chemotherapy: brain tissue profiles after ventriculocisternal perfusion. J Pharmacol Exp Ther 195: 73–83, 1975
Sendelbeck SL, Urquhart J: Spatial distribution of dopamine, methotrexate and antipyrine during continous intracerebral microperfusion. Brain Res 328: 251–258, 1985
Cheng CJ, Fujimura S, Grunberger D, Weinstein IB: Interaction of CCNU with nucleic acid and proteins in vivo and in vitro. Cancer Res 32: 22–27, 1972
Kohn KW: Interstrand cross-linking of DNA by 1,3-bis(2-chloroethyl)-1-nitrosourea and other 1-(2-haloethyl)-1-nitrosourea. Cancer Res 37: 1450–1454, 1977
Hayakawa T, Yamada R, Kanai N, Kuroda R, Ushio Y, Higashi H, Mogami H: Intrathecal chemotherapy. Selection of cytostatic agents. Brit J Cancer 24: 489–497, 1970
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Huang, TY., Arita, N., Hayakawa, T. et al. ACNU, MTX And 5-FU Penetration of Rat Brain Tissue and Tumors. J Neurooncol 45, 9–17 (1999). https://doi.org/10.1023/A:1006377312403
Issue Date:
DOI: https://doi.org/10.1023/A:1006377312403